• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(CSE:ONCO)

1.410 UNCHANGED
Last Price Updated: 4:00 PM EDT, May 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.410
Bid (Size) 1.420 (400)
Ask (Size) 1.420 (1,000)
Prev. Close 1.410
Today's Range 1.410 - 1.410
52wk Range 0.9000 - 2.800
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
February 04, 2026
Via ACCESS Newswire
News headline image
Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
January 21, 2026
Via ACCESS Newswire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-32.2%
-32.2%

More News

Read More
News headline image
Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care
December 09, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Engages Investment Bank to Pursue Nasdaq Cross-listing and Potential Concurrent Equity Offering
December 07, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
November 25, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
November 20, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
November 18, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment
November 07, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight
October 31, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Appoints Jared Rushton to Board of Directors
October 30, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Closing of Private Placement
October 27, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Private Placement
October 14, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology
September 29, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Appoints Dr. Michael Lock to Scientific & Clinical Advisory Board
September 22, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies
September 19, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations to Chair Colorectal Cancer Canada Precision Oncology Forum Driving the Future of Cancer Care
September 12, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Appoints Dr. John Mackey to Scientific & Clinical Advisory Board
September 05, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Announces 90% of $0.60 Warrants Have Been Exercised
August 15, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Closing of Private Placement
August 13, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Advances Progress Towards First-in-Human Trial with Avance Clinical Start-Up Agreement
August 04, 2025
Via ACCESS Newswire
News headline image
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms
July 30, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Announces Private Placement
July 29, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board
July 21, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology
July 11, 2025
Via ACCESS Newswire
News headline image
Onco-Innovations Strengthens Clinical Leadership with Appointment of Dr. Islam Mohamed as Advisory Board Chair
July 10, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is ONCO publicly traded?
Yes, ONCO is publicly traded.
What exchange does ONCO trade on?
ONCO trades on the Canadian Securities Exchange
What is the ticker symbol for ONCO?
The ticker symbol for ONCO is ONCO on the Canadian Securities Exchange
What is the current price of ONCO?
The current price of ONCO is 1.410
When was ONCO last traded?
The last trade of ONCO was at 05/23/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap